REFERENCES:
1. Wang, N., Yin, R., Liu, Y., Mao, G., and
Xi, F. Role of peroxisome proliferator-activated receptor-γ in atherosclerosis:
An update. Circulation Journal.
2011; 75(3).
2. Kishan L. Jadhav, Priyanka
R. Kapare, Divya V. Khairmode, Chaitali H. Keskar, Farida Shaikh, Shradda
Sawant, Akash S. Mali. Genetic Insights of Cholesterol and Atherosclerosis:
Complex Biology. Asian Journal of Pharmaceutical Research. 2018; 8 (3): 175-184
3. Yuan, Y., Li, P., and Ye, J. Lipid
homeostasis and the formation of macrophage-derived foam cells in
atherosclerosis. Protein and Cell.
2012; 3(3): 173–181.
4. Hopkins, P. N. Molecular Biology of
Atherosclerosis. Physiol Rev.
2013; 93: 1317–1542
5. Kajal, A., Kishore, L., Kaur, N.,
Gollen, R., and Singh, R. Therapeutic agents for the management of
atherosclerosis from herbal sources. Beni-Suef
University Journal of Basic and Applied Sciences. 2016; 5(2): 156–169.
6.
J. Lakshmi
Prabha, M. Sankari. Role of Il-1 in Atherosclerosis. Research J. Pharm. and
Tech 2018; 11(7): 3163-3166.
7. Mozaffarian, D., Benjamin, E. J., Go,
A. S., Arnett, D. K., Blaha, M. J., Cushman, M., … Turner, M. B. AHA Statistical Update Heart Disease and
Stroke Statistics — 2016 Update A Report From the American Heart Association
Writing Group Members. 2016.
8.
Fadhil A. Rizij .
Anti-inflammatory, Anti-oxidative and Athero-protective effects of Irbesartan
in rabbits with Atherogenic diet. Research J. Pharm. and Tech 2018; 11(10):
4324-4328.
9. Chandra, M., Miriyala, S., and Panchatcharam, M.
(2017). PPARγ and Its Role in Cardiovascular Diseases. Current Opinion in Cardiology. 2017; 32(6): 761–766.
10. Jeyabaskar Suganya, Viswanathan T, Mahendran Radha,
Nishandhini Marimuthu. In silico Molecular Docking studies to investigate interactions
of natural Camptothecin molecule with diabetic enzymes. Research J. Pharm. and
Tech. 2017; 10(9): 2917-2922.
11. Wang, L., Waltenberger, B.,
Pferschy-Wenzig, E. M., Blunder, M., Liu, X., Malainer, C., … Atanasov, A. G.
Natural product agonists of peroxisome proliferator-activated receptor gamma
(PPARγ): A review. Biochemical
Pharmacology. 2014; 92(1):
73–89.
12. Ouimet, M., and Marcel, Y. L. Regulation
of Lipid Droplet Cholesterol Efflux from Macrophage Foam Cells. Arteriosclerosis, thrombosis, and vascular
biology. 2012; 32(3):
575–81.
13. Iizuka, M., Ayaori, M., Uto-Kondo, H., Yakushiji, E.,
Takiguchi, S., Nakaya, K., Ikewaki, K. Astaxanthin enhances ATP-binding
cassette transporter A1/G1 expressions and cholesterol efflux from macrophages.
Journal of Nutritional Science and
Vitaminology. 2012; 58(2):
96–104.
14. Song, Y., Zhang, L.-J., Li, H., Gu,
Y., Li, F.-F., Jiang, L.-N., … Li, Q. Polyunsaturated fatty acid relatively
decreases cholesterol content in THP-1 macrophage-derived foam cell: partly correlates
with expression profile of CIDE and PAT members. Lipids in Health and Disease. 2013; 12: 111.
15. Okuhira, K., Fitzgerald, M. L., Tamehiro, N., Ohoka,
N., Suzuki, K., and Sawada, J. Binding of PDZ-RhoGEF to ATP-binding Cassette
Transporter A1 (ABCA1) Induces Cholesterol Efflux through RhoA Activation and
Prevention of Transporter Degradation. J
Biol Chem. 2010; 285:
16369–16377.
16. Yvan-Charvet, L., Wang, N., and Tall, A. R. Role of
HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses. Arteriosclerosis, Thrombosis, and Vascular
Biology. 2010; 30(2):
139–143.
17. Matsumura, T., Kinoshita, H., Ishii, N., Fukuda, K.,
Motoshima, H., Senokuchi, T., … Kawada, T. Telmisartan Exerts Antiatherosclerotic
Effects by Activating in Macrophages. Arterioscler Thromb Vasc Biol. 2011; 31: 1268-1275.
18. Phillips, M. C. Molecular Mechanisms of Cellular
Cholesterol Efflux. Journal of
Biological Chemistry. 2014; 289(35):
24020–24029.
19. Triana, R., Dewi, N. M., Darmayanti, S., Herawati, E.,
Novalentina, M., Semadhi, M. P., and Rahman, M. N. PPAR-gamma Signaling in
Metabolic Homeostasis. The Indonesian
Biomedical Journal. 2016; 8(3):
147-156.
20. Nikolic, D., Castellino, G., Banach, M., Toth, P.,
Ivanova, E., Orekhov, A., … Rizzo, M. PPAR Agonists, Atherogenic Dyslipidemia
and Cardiovascular Risk. Current
Pharmaceutical Design. 2016; 23(6):
894–902.
21. Sotherden, G. M., Uto-kondo, H.,
Ayaori, M., and Ikewaki, K. Effects of Nutraceuticals and Botanicals on
Cholesterol Efflux : Implications for Atherosclerosis Macrophage. Journal of Nutritional Therapeutics.
2012; 1: 96–106.
22. Nilesh Gupta, U.K Jain, Ankit Jain, Goutam Lovanshi,
Nitin Mathan, Vipin Tiwari. Review of Some Important Medicinal Plants Possesses
Anti-Inflammatory Activity. Research J. Pharm. and Tech. 2011;4(10): 1506-1512.
23. Suja C, Shuhaib. B, Muhammed Abdurahman, Hunaida
Khathoom, Simi K. A Review on Dietary Antioxidants. Research J. Pharm. and
Tech. 2016; 9(2): 196-202.
24. Ha, L. M., Huyen, D. T. T., Kiem, P. Van,
Minh, C. Van, Van, N. T. H., Nhiem, N. X., Kim, Y. H. Chemical Constituents of
the Rhizome of Eleutherine Bulbosa and Their Inhibitory Effect on the
Pro-Inflammatory Cytokines Production in Lipopolysaccharide -Stimulated Bone
Marrow-derived Dendritic Cells. Journal
of Chemical Information and Modeling. 2013; 53: 1689–1699.
25. Insanu, M., Kusmardiyani, S., and Hartati, R. Recent
Studies on Phytochemicals and Pharmacological Effects of Eleutherine Americana
Merr. Procedia Chemistry. 2014;
13: 221–228.
26. Daniel Silas Samuel, R.V.Geetha. Antioxidant Activity
of Dry Fruits: A Short Review. Research J. Pharm. and Tech. 2014; 7(11):
1319-1322.
27. Pratiwi, D., Wahdaningsih, S., and
Isnindar. The Test of Antioxidant Activity from Bawang Mekah Leaves
(Eleutherine Americana Merr.) Using Dpph (2,2- Diphenyl-1-Picrylhydrazyl)
Method. Trad. Med. J. 2013; 18: 10–11.
28. Sirirak, T., and Voravuthikunchai, S.
P. Eleutherine americana: A candidate for the control of Campylobacter species.
Poultry Science. 2011; 90(4): 791–796.
29. Subramaniam, K., Suriyamoorthy, S.,
Wahab, F., Sharon, F. B., and Rex, G. R. Antagonistic activity of Eleutherine
palmifolia Linn. Asian Pacific Journal
of Tropical Disease. 2012; 2:
S491–S493.
30. Ieyama, T., Gunawan-Puteri, M. D. P. T., and Kawabata,
J. α-Glucosidase Inhibitors from the Bulb of Eleutherine americana. Food Chemistry. 2011; 128(2): 308–311.
31. Amelia, T., Pratiwi, D., Romsiah, and
Tjahjono, D. H. In Silico Study of The Component of Eleutherine americana MERR.
on Human Estrogen Reseptor Alpha as Potential Anti-Breast Cancer. 3rd International Conference on Computation
for Science and Technology (ICCST-3). 2012; 33: 3–8.
32. Kusuma, I. W., Arung, E. T., Rosamah,
E., Purwatiningsih, S., Kuspradini, H., Syafrizal, … Shimizu, K.
Antidermatophyte and antimelanogenesis compound from Eleutherine americana
grown in Indonesia. Journal of Natural
Medicines. 2010; 64(2):
223–226.
33. Sathish Babu. P, Gokula Krishnan, Anand Babu.K,
Chitra. K. In silico and In vitro Evaluation of Anti-urolithiatic Activity of
Ethanolic Extract of Syzygium cumini Stem Bark. Research J. Pharm. and Tech.
2017; 10(5): 1317-1321.
34. R. Sathish Kumar, C. Aarthi. Insilico Prediction of
Binding Efficiency for the Phytoconstituents from Traditional Medicinal Plants
against Diabetes Target: Aldose Reductase. Research J. Pharm. and Tech 2017;
10(11): 3709-3712.
35. Radha Mahendran, Suganya Jeyabasker, Astral Francis,
Sharanya Manoharan. Homology Modeling and in silico docking analysis of BDNF in
the treatment of Alzheimer’s disease. Research J. Pharm. and Tech. 2017; 10(9):
2899-2906.
36.
Jeyabaskar
Suganya, Sharanya Manoharan, Mahendran Radha, Neha Singh, Astral Francis.
Identification and Analysis of Natural Compounds as Fungal Inhibitors from
Ocimum sanctum using in silico Virtual Screening and Molecular Docking. Research
J. Pharm. and Tech 2017; 10(10):3369-3374.